MedTrace Logo

An Approach to Screening for COVID-19 at Vancouver Airport

NCT04665193 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 592

Last updated 2021-05-04

No results posted yet for this study

Summary

The primary objective of this pilot study is to determine the feasibility and effectiveness of a COVID-19 screening program for passengers departing from YVR. This research study is conducted by The University of British Columbia (UBC) and Providence Health Care, sponsored by WestJet and Vancouver Airport Authority. The experimental study investigates point-of-care rapid test device for detecting SARS-CoV-2, the virus responsible for COVID-19. The study is investigating a method of rapid-testing for COVID-19 and will help inform the safest and most efficient way of testing departing passengers prior to security screening at Vancouver International Airport (YVR). This study is also evaluating a new passenger management system.

Conditions

  • Asymptomatic Condition
  • Healthy

Interventions

DIAGNOSTIC_TEST

Rapid Antigen Test

Antigen Technology Lab-based test and Point of care test

Sponsors & Collaborators

  • Vancouver Airport Authority

    collaborator UNKNOWN

  • WestJet Airlines

    collaborator UNKNOWN

  • Providence Health & Services

    collaborator OTHER

  • KLM Royal Dutch Airlines

    collaborator UNKNOWN

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Don Sin, MD · University of British Columbia

  • Marc Romney, MD · University of British Columbia

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
13 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-23
Primary Completion
2021-02-28
Completion
2021-04-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04665193 on ClinicalTrials.gov